fda warning letters compounded semaglutide tirzepatide 2025 issued 25 to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Sends 30 Warning Letters

Toxicol Appl Pharmacol 370:3643 Alamri HS, Alsughayyir J, Akiel M et al (2021) Stimulation of calcium influx and CK1 by NF-B antagonist [6]-Gingerol reprograms red blood cell longevity

Am J Clin Nutr 64 : 587593

Metabolic and Appetite Regulation: By interacting with MC3 and MC4 receptors, the peptide serves as a reference standard in studies investigating feeding behavior, energy expenditure, and metabolic pathways

It is particularly useful for: Fair-skinned individuals who burn easily Those with photosensitivity disorders (e.g., lupus) Patients wishing to reduce sun damage or avoid artificial tanning 2

Tirzepatide generally produces greater average weight loss than semaglutide in clinical studies